EXAS: Exact Sciences Corporation Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 11,417.36
Enterprise Value ($M) 13,397.05
Book Value ($M) 3,210.51
Book Value / Share 17.35
Price / Book 3.56
NCAV ($M) -2,004.94
NCAV / Share -10.83
Price / NCAV -5.69

Profitability (mra)
Return on Invested Capital (ROIC) -0.04
Return on Assets (ROA) -0.03
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 1.93
Current Ratio 2.12

Balance Sheet (mrq) ($M)
Current Assets 1,533.12
Assets 6,748.57
Liabilities 3,538.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-13 13G Capital World Investors 8.60 238.28
11-08 13G/A Wellington Management Group Llp 7.93 39.06
10-07 13G Fmr Llc 11.90 740.43
06-07 13G/A Jpmorgan Chase & Co 4.00 -56.63
02-13 13G/A Vanguard Group Inc 9.71 1.78
01-29 13G/A BlackRock, Inc. 6.10 -2.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-12-03 323,731 1,423,797 22.74
2024-12-02 380,101 1,528,316 24.87
2024-11-29 256,523 963,187 26.63

(click for more detail)

Similar Companies
BGLC – BioNexus Gene Lab Corp. CELC – Celcuity Inc.
MDXH – MDxHealth SA PMD – Psychemedics Corporation
VRDN – Viridian Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.